Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Q: What does CUSIP 221015100 represent in this 13F holders report?

CUSIP 221015100 is the security identifier for CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q3 2019?

34 institutional investors reported CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q3 2019. Use the holders table for investor-level position and value details.

CUSIP: 221015100

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 91,091,040
Total 13F shares: 22,891,685
Share change: -1,264,969
Total reported value: $68,903,436
Price per share: $3.01
Number of holders: 34
Value change: -$4,060,912
Number of buys: 16
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 221015100?
CUSIP 221015100 identifies CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2019
Previous quarter: Q2 2019

Recent filing periods for CUSIP 221015100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	7.2%	6,565,685	$24,556,000	—	30 Jun 2019	13F
Novo Holdings A/S	13F	Company	4.9%	4,420,516	$16,533,000	—	30 Jun 2019	13F
ADAMS STREET PARTNERS LLC	13F	Company	3.6%	3,275,616	$12,251,000	—	30 Jun 2019	13F
BVF INC/IL	13F	Company	3%	2,774,750	$10,378,000	—	30 Jun 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.9%	1,762,248	$6,591,000	—	30 Jun 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.91%	833,098	$3,116,000	—	30 Jun 2019	13F
FMR LLC	13F	Company	0.63%	577,856	$2,161,000	—	30 Jun 2019	13F
COWEN INC.	13F	Company	0.63%	576,231	$2,155,000	—	30 Jun 2019	13F
VANGUARD GROUP INC	13F	Company	0.54%	487,636	$1,824,000	—	30 Jun 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.51%	468,534	$1,752,000	—	30 Jun 2019	13F
Rock Springs Capital Management LP	13F	Company	0.44%	400,000	$1,496,000	—	30 Jun 2019	13F
BlackRock Finance, Inc.	13F	Company	0.37%	332,934	$1,244,000	—	30 Jun 2019	13F
Puissance Capital Management LP	13F	Company	0.31%	284,869	$1,065,000	—	30 Jun 2019	13F
Fosun International Ltd	13F	Company	0.2%	184,116	$624,000	—	30 Jun 2019	13F
NORTHERN TRUST CORP	13F	Company	0.16%	141,717	$530,000	—	30 Jun 2019	13F
Hikari Power Ltd	13F	Company	0.14%	130,000	$486,000	—	30 Jun 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.13%	118,632	$442,000	—	30 Jun 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	114,794	$429,000	—	30 Jun 2019	13F
Telemetry Investments, L.L.C.	13F	Company	0.11%	101,218	$379,000	—	30 Jun 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.1%	94,696	$354,000	—	30 Jun 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.09%	78,244	$293,000	—	30 Jun 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.08%	74,735	$280,000	—	30 Jun 2019	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.07%	64,325	$241,000	—	30 Jun 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	60,832	$228,000	—	30 Jun 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.07%	66,687	$226,000	—	30 Jun 2019	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.07%	59,718	$223,000	—	30 Jun 2019	13F
TD ASSET MANAGEMENT INC	13F	Company	0.05%	49,578	$185,000	—	30 Jun 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	46,904	$175,000	—	30 Jun 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.05%	42,394	$159,000	—	30 Jun 2019	13F
Paloma Partners Management Co	13F	Company	0.04%	39,787	$149,000	—	30 Jun 2019	13F
MORGAN STANLEY	13F	Company	0.04%	32,616	$122,000	—	30 Jun 2019	13F
STATE STREET CORP	13F	Company	0.02%	20,510	$77,000	—	30 Jun 2019	13F
BARCLAYS PLC	13F	Company	0.01%	13,556	$51,000	—	30 Jun 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.01%	13,359	$50,000	—	30 Jun 2019	13F
RAYMOND JAMES TRUST N.A.	13F	Company	0.01%	13,158	$49,000	—	30 Jun 2019	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.01%	12,594	$47,000	—	30 Jun 2019	13F
Legal & General Group Plc	13F	Company	0%	2,059	$7,000	—	30 Jun 2019	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	1,806	$6,754	—	30 Jun 2019	13F
CITIGROUP INC	13F	Company	0%	1,564	$6,000	—	30 Jun 2019	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	1,006	$4,000	—	30 Jun 2019	13F
Advisor Group, Inc.	13F	Company	0%	1,000	$4,000	—	30 Jun 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	676	$3,000	—	30 Jun 2019	13F
Proficio Capital Partners LLC	13F	Company	0%	324	$1,000	—	30 Jun 2019	13F

Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q3 2019

As of 30 Sep 2019, Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,891,685 shares. The largest 10 holders included ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, BVF INC/IL, Novo Holdings A/S, PRICE T ROWE ASSOCIATES INC /MD/, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, and FMR LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q3 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders

Q3 2019 holders

Holder diff

-9

Investor	Q2 2019 Shares	Q3 2019 Shares	Share Diff	Share Chg %	Q2 2019 Value $	Q3 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.